Holen Sie sich die Stockscreener-App
1.13
8.87%
-0.11
Schlusskurs vom Vortag:
$1.24
Offen:
$1.23
24-Stunden-Volumen:
141.12K
Relative Volume:
0.08
Marktkapitalisierung:
$14.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.92M
KGV:
-0.0246
EPS:
-45.8429
Netto-Cashflow:
$-401.10K
1W Leistung:
-23.65%
1M Leistung:
-36.16%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.07
$1.26
1-Wochen-Bereich:
$1.07
$1.49
52-Wochen-Spanne:
$1.07
$9.36
Propanc Biopharma Inc Stock (PPCB) Company Profile
Firmenname
Propanc Biopharma Inc
Sektor
Branche
Telefon
61-03-9882-0780
Adresse
302/6 BUTLER STREET, CAMBERWELL, VICTORIA
Vergleichen Sie PPCB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPCB
Propanc Biopharma Inc
|
2.87 | 244.39K | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
3.17 | 4.40B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.96 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
5.05 | 189.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.237 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.40 | 0 | 0 | 0 | 0 | 0.00 |
Propanc Biopharma Inc Aktie (PPCB) Neueste Nachrichten
Propanc Biopharma, Inc. Announces Strategic Initiative to Acquire Undervalued Digital Asset Treasury Companies - Quiver Quantitative
Propanc Biopharma plans digital asset company acquisitions - Investing.com
Propanc Biopharma plans to acquire digital asset treasury companies - Investing.com
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan - GlobeNewswire
Propanc Biopharma, Inc. (PPCB) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital - The Manila Times
CORRECTION: Propanc Biopharma Announces Strategic Financing - GlobeNewswire
Up to $100M strategic financing — Propanc Biopharma issues $1M Series C convertible, warrants attached - Stock Titan
Propanc Biopharma announces up to $100M strategic financing from Hexstone Capital - MSN
Propanc Biopharma announces financing agreement up to $100M - TipRanks
Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital - The Manila Times
Propanc Biopharma announces strategic financing agreement of up to $100 million with Hexstone Capital - MarketScreener
Propanc Biopharma Announces Strategic Financing Agreement Of Up To $100 Million With Hexstone Capital - TradingView
Up to $100M strategic financing: Propanc Biopharma and Hexstone agree with $5.00 conversion price - Stock Titan
Ethereum treasury company Propanc Biopharma reaches up to $100 million strategic financing agreement with Hexstone Capital - Bitget
Propanc Biopharma Enters Securities Purchase Agreement - MSN
Propanc Biopharma enters agreement for Series C preferred stock private placement By Investing.com - Investing.com South Africa
Propanc Biopharma enters agreement for Series C preferred stock private placement - Investing.com UK
Propanc Biopharma receives certificate of grant from USPTO - MSN
Propanc Biopharma closes public offering, uplists to NASDAQ - MSN
Propanc Biopharma (OTCMKTS:PPCB) Stock Price Down 2.6% – Time to Sell? - Defense World
Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development and $100M+ Digital Asset Treasury Strategy - MarketScreener
Propanc Biopharma reports major financial turnaround after Nasdaq uplisting By Investing.com - Investing.com Nigeria
Propanc Biopharma reports major financial transformation after Nasdaq listing - Investing.com
Propanc reports $100 million digital asset treasury plan, NASDAQ listing By Investing.com - Investing.com Nigeria
Propanc Biopharma plans $100M digital asset treasury strategy By Investing.com - Investing.com Australia
Propanc Biopharma reports total assets of $19.6M as of June 30 - TipRanks
Propanc Biopharma reports major financial turnaround after Nasdaq uplisting - Investing.com India
Propanc Biopharma reports major financial transformation after Nasdaq listing By Investing.com - Investing.com Australia
Propanc Biopharma Reports Fiscal Year-End Update and Strategic Developments Following Nasdaq Uplisting - Quiver Quantitative
Propanc reports $100 million digital asset treasury plan, NASDAQ listing - Investing.com India
Propanc Biopharma plans $100M digital asset treasury strategy - Investing.com
Propanc Reports End of Fiscal Year Highlights and Outlines - GlobeNewswire
Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy - MarketScreener
$100M+ Digital Treasury Plan: Propanc Pursues Crypto Strategy After Nasdaq Uplisting and $19.6M Assets - Stock Titan
From Lab Bench to Blockchain: How Biotech is Reinventing Funding - The Globe and Mail
Propanc Biopharma, Inc. announced a financing transaction - MarketScreener
Does Propanc Biopharma (NASDAQ:PPCB) Have A Healthy Balance Sheet? - simplywall.st
Propanc Biopharma, Inc. SEC 10-K Report - TradingView
Propanc Biopharma prices $4M stock offering - MSN
Crypto and Cancer: How Biotech’s New Strategy Is Turning Heads - The Globe and Mail
Reviewing Immatics (NASDAQ:IMTX) & Propanc Biopharma (OTCMKTS:PPCB) - Defense World
Propanc receives US patent for proenzyme cancer treatment composition By Investing.com - Investing.com South Africa
Propanc receives US patent for proenzyme cancer treatment composition - Investing.com
Propanc Biopharma Receives Certificate of Grant for 'Proenzyme Composition” Patent from US Patent & Trademark Office - The Manila Times
Propanc Biopharma Receives Certificate of Grant for - GlobeNewswire
$111.2B Market Opportunity: Propanc's Non-Toxic Cancer Drug PRP Receives Critical USPTO Patent - Stock Titan
Propanc Biopharma announces plan to acquire $100 million of Ethereum - MSN
Propanc to acquire $100M of Ethereum to accelerate pipeline - BioWorld MedTech
Finanzdaten der Propanc Biopharma Inc-Aktie (PPCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):